For example, eosinophil and T cell-derived IL-22BP is pathogenic in an inflammatory setting associated with IBD, however dendritic cell-derived IL-22BP protects against colorectal cancer [10,27,36]. This evidence concerns the gene IL22RA2 and inflammatory bowel disease.